The most important way to prevent atherosclerotic cardiovascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life.

Guideline

• 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
• 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
• 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
• 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
• 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk

Expert Consensus Documents

• 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment
• 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
• 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk

Certified Education

• Guideline Education: Non-Pharmacologic Management of Hypertension
• Role of Ezetimibe in Secondary Prevention of CAD
• Guideline Education: Treating Hypertension in the African American Patient
• Guideline Education: Diagnosis and Management of Hypertension
• Guideline Education: Managing the Complex Hypertensive Patient With Chronic Kidney Disease
• Guideline Education: Making the Case for Intensification of Statins
• Guideline Education: Presence of Subclinical Atherosclerosis on CAC Scoring

Back to Guideline Education landing page >>>